BON Stock Overview
Engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Bon Natural Life Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.47 |
| 52 Week High | US$6.00 |
| 52 Week Low | US$1.23 |
| Beta | -1.05 |
| 1 Month Change | -6.37% |
| 3 Month Change | -11.44% |
| 1 Year Change | -74.21% |
| 3 Year Change | -96.89% |
| 5 Year Change | n/a |
| Change since IPO | -97.96% |
Recent News & Updates
Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 13
Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 13Recent updates
Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 13Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 13Bon Natural Life Limited's (NASDAQ:BON) Shares Not Telling The Full Story
Apr 30Fewer Investors Than Expected Jumping On Bon Natural Life Limited (NASDAQ:BON)
Jan 27Bon Natural Life's (NASDAQ:BON) Returns Have Hit A Wall
Nov 13Returns on Capital Paint A Bright Future For Bon Natural Life (NASDAQ:BON)
Aug 15Why We Like The Returns At Bon Natural Life (NASDAQ:BON)
May 01The Returns At Bon Natural Life (NASDAQ:BON) Aren't Growing
Jan 16We Think That There Are Some Issues For Bon Natural Life (NASDAQ:BON) Beyond Its Promising Earnings
Aug 08Bon Natural Life GAAP EPS of $0.30, revenue of $13.7M
Aug 01Bon Natural Life (NASDAQ:BON) Is Experiencing Growth In Returns On Capital
Jun 24A Piece Of The Puzzle Missing From Bon Natural Life Limited's (NASDAQ:BON) 41% Share Price Climb
Mar 05Shareholder Returns
| BON | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -13.5% | -4.3% | -2.4% |
| 1Y | -74.2% | -3.4% | 23.4% |
Return vs Industry: BON underperformed the US Chemicals industry which returned -3.4% over the past year.
Return vs Market: BON underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| BON volatility | |
|---|---|
| BON Average Weekly Movement | 12.6% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BON's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BON's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 96 | Yongwei Hu | www.bnlus.com |
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
Bon Natural Life Limited Fundamentals Summary
| BON fundamental statistics | |
|---|---|
| Market cap | US$5.84m |
| Earnings (TTM) | US$2.47m |
| Revenue (TTM) | US$25.56m |
2.4x
P/E Ratio0.2x
P/S RatioIs BON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BON income statement (TTM) | |
|---|---|
| Revenue | US$25.56m |
| Cost of Revenue | US$18.46m |
| Gross Profit | US$7.09m |
| Other Expenses | US$4.63m |
| Earnings | US$2.47m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 27.75% |
| Net Profit Margin | 9.65% |
| Debt/Equity Ratio | 17.3% |
How did BON perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:24 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bon Natural Life Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hunter Diamond | Diamond Equity Research LLC |